These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 37218551)

  • 1. A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry.
    Begum F; Srivastava AK; Tripathi PP; Ray U
    J Med Virol; 2023 May; 95(5):e28796. PubMed ID: 37218551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein.
    Matveev EV; Ponomarev GV; Kazanov MD
    Microbiol Spectr; 2024 Feb; 12(2):e0353023. PubMed ID: 38189333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    Lavie M; Dubuisson J; Belouzard S
    J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.
    Tang T; Jaimes JA; Bidon MK; Straus MR; Daniel S; Whittaker GR
    ACS Infect Dis; 2021 Feb; 7(2):264-272. PubMed ID: 33432808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein.
    Ho C; Nazarie WFWM; Lee PC
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of host proteases in the entry of SARS-CoV-2.
    Zabiegala A; Kim Y; Chang KO
    Anim Dis; 2023; 3(1):12. PubMed ID: 37128508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein.
    Yamamoto M; Gohda J; Kobayashi A; Tomita K; Hirayama Y; Koshikawa N; Seiki M; Semba K; Akiyama T; Kawaguchi Y; Inoue JI
    mBio; 2022 Aug; 13(4):e0051922. PubMed ID: 35708281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein.
    Kleine-Weber H; Elzayat MT; Hoffmann M; Pöhlmann S
    Sci Rep; 2018 Nov; 8(1):16597. PubMed ID: 30413791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.
    Belouzard S; Chu VC; Whittaker GR
    Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5871-6. PubMed ID: 19321428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope-directed anti-SARS-CoV-2 scFv engineered against the key spike protein region could block membrane fusion.
    Jaiswal D; Kumar U; Gaur V; Salunke DM
    Protein Sci; 2023 Mar; 32(3):e4575. PubMed ID: 36691733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
    Mondal T; Shivange G; Habieb A; Tushir-Singh J
    Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.
    Winstone H; Lista MJ; Reid AC; Bouton C; Pickering S; Galao RP; Kerridge C; Doores KJ; Swanson CM; Neil SJD
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33563656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.
    Laporte M; Raeymaekers V; Van Berwaer R; Vandeput J; Marchand-Casas I; Thibaut HJ; Van Looveren D; Martens K; Hoffmann M; Maes P; Pöhlmann S; Naesens L; Stevaert A
    PLoS Pathog; 2021 Apr; 17(4):e1009500. PubMed ID: 33886690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.
    Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V.
    Bollavaram K; Leeman TH; Lee MW; Kulkarni A; Upshaw SG; Yang J; Song H; Platt MO
    Protein Sci; 2021 Jun; 30(6):1131-1143. PubMed ID: 33786919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
    Navaratnarajah CK; Pease DR; Halfmann PJ; Taye B; Barkhymer A; Howell KG; Charlesworth JE; Christensen TA; Kawaoka Y; Cattaneo R; Schneider JW;
    J Virol; 2021 Nov; 95(24):e0136821. PubMed ID: 34613786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion.
    Barrett CT; Neal HE; Edmonds K; Moncman CL; Thompson R; Branttie JM; Boggs KB; Wu CY; Leung DW; Dutch RE
    J Biol Chem; 2021 Jul; 297(1):100902. PubMed ID: 34157282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
    Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
    mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic activation of SARS-CoV-2 spike protein.
    Takeda M
    Microbiol Immunol; 2022 Jan; 66(1):15-23. PubMed ID: 34561887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.